Literature DB >> 33523213

Adiposity rebound and cardiometabolic health in childhood: results from the Generation XXI birth cohort.

Maria João Fonseca1, Carla Moreira1,2, Ana Cristina Santos1,3.   

Abstract

BACKGROUND: We aimed to evaluate the association of adiposity rebound (AR) timing on cardiometabolic health in childhood.
METHODS: Participants were part of the Generation XXI birth cohort, enrolled in 2005/2006 in Porto. All measurements of the child's weight and height performed by health professionals as part of routine healthcare were collected. Individual body mass index (BMI) curves were fitted for 3372 children, using mixed-effects models with smooth spline functions for age and random effects. The AR was categorized into very early (<42 months), early (42-59 months), normal (60-83 months) and late (≥84 months). At age 10 years, cardiometabolic traits were assessed and age- and sex-specific z-scores were generated. Adjusted regression coefficients and 95% confidence intervals [β (95% CI)] were computed.
RESULTS: The mean age at AR was 61.9 months (standard deviations 15.7). Compared with children with normal AR, children with very early or early AR had higher z-scores for BMI [β = 0.40 (95% CI: 0.28; 0.53); β = 0.21 (95% CI: 0.12; 0.30)], waist circumference [β = 0.33 (95% CI: 0.23; 0.43); β = 0.18 (95% CI: 0.10; 0.25)], waist-height ratio [β = 0.34 (95% CI: 0.24; 0.44); β = 0.14 (95% CI: 0.07; 0.22)], fat mass index [β = 0.24 (95% CI: 0.15; 0.33); β = 0.14 (95% CI: 0.08; 0.21)], fat-free mass index [β = 0.25 (95% CI: 0.14; 0.35); β = 0.11 (95% CI: 0.03; 0.19)], systolic blood pressure [β = 0.10 (95% CI: 0.01; 0.20); β = 0.08 (95% CI: 0.01; 0.15)], insulin [β = 0.16 (95% CI: 0.04; 0.29); β = 0.10 (95% CI: 0.01; 0.19)], HOMA-IR [β = 0.17 (95% CI: 0.04; 0.29); β = 0.10 (95% CI: 0.03; 0.19)] and C-reactive protein [β = 0.14 (95% CI: 0.02; 0.26); β = 0.10 (95% CI: 0.01; 0.19)]. Children with very early AR also had worse levels of diastolic blood pressure [β = 0.09 (95% CI: 0.02; 0.16)], triglycerides [β = 0.21 (95% CI: 0.08; 0.34)] and high-density lipoprotein cholesterol [β=-0.18 (95% CI: -0.31; -0.04)]. When analysed continuously, each additional month of age at the AR was associated with healthier cardiometabolic traits.
CONCLUSION: The earlier the AR, the worse the cardiometabolic health in late childhood, which was consistently shown across a wide range of outcomes and in the categorical and continuous approach.
© The Author(s) 2021; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

Entities:  

Keywords:  Growth; adiposity rebound; birth cohort; cardiometabolic health; early rebounders

Year:  2021        PMID: 33523213     DOI: 10.1093/ije/dyab002

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  4 in total

Review 1.  Age at adiposity rebound and the relevance for obesity: a systematic review and meta-analysis.

Authors:  Jixing Zhou; Fu Zhang; Xiaoyun Qin; Peixuan Li; Yuzhu Teng; Shanshan Zhang; Fangbiao Tao; Kun Huang
Journal:  Int J Obes (Lond)       Date:  2022-04-18       Impact factor: 5.551

2.  Pre-Birth and Early-Life Factors Associated With the Timing of Adiposity Peak and Rebound: A Large Population-Based Longitudinal Study.

Authors:  Dan Lin; Didi Chen; Jun Huang; Yun Li; Xiaosa Wen; Ling Wang; Huijing Shi
Journal:  Front Pediatr       Date:  2021-12-22       Impact factor: 3.418

3.  Using linear and natural cubic splines, SITAR, and latent trajectory models to characterise nonlinear longitudinal growth trajectories in cohort studies.

Authors:  Ahmed Elhakeem; Rachael A Hughes; Kate Tilling; Diana L Cousminer; Stefan A Jackowski; Tim J Cole; Alex S F Kwong; Zheyuan Li; Struan F A Grant; Adam D G Baxter-Jones; Babette S Zemel; Deborah A Lawlor
Journal:  BMC Med Res Methodol       Date:  2022-03-15       Impact factor: 4.612

4.  Longitudinal association between the timing of adiposity peak and rebound and overweight at seven years of age.

Authors:  Dan Lin; Di-di Chen; Jun Huang; Yun Li; Xiao-Sa Wen; Hui-Jing Shi
Journal:  BMC Pediatr       Date:  2022-04-19       Impact factor: 2.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.